Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Dankner

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The Journal of Infectious Diseases|September 5, 1998
Genetic diversity among Mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infectionD S Swanson, X Pan, M W Kline, et al.
Ophthalmology|July 1, 1993
Pathophysiology and treatment of clinically resistant cytomegalovirus retinitisM Flores-Aguilar, B D Kuppermann, J I Quiceno, et al.
Pediatrics|April 2, 1999
A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 TeamM W Kline, S Blanchard, C V Fletcher, et al.
The Journal of Infectious Diseases|May 24, 2000
Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virusJ C King, W Borkowsky, N Mahidhara, et al.
The New England Journal of Medicine|December 22, 1999
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 TeamS E Starr, C V Fletcher, S A Spector, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The Journal of Infectious Diseases|September 5, 1998
Genetic diversity among Mycobacterium avium complex strains recovered from children with and without human immunodeficiency virus infectionD S Swanson, X Pan, M W Kline, et al.
Ophthalmology|July 1, 1993
Pathophysiology and treatment of clinically resistant cytomegalovirus retinitisM Flores-Aguilar, B D Kuppermann, J I Quiceno, et al.
Pediatrics|April 2, 1999
A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 TeamM W Kline, S Blanchard, C V Fletcher, et al.
The Journal of Infectious Diseases|May 24, 2000
Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virusJ C King, W Borkowsky, N Mahidhara, et al.
The New England Journal of Medicine|December 22, 1999
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 TeamS E Starr, C V Fletcher, S A Spector, et al.
The Journal of Infectious Diseases|November 9, 2000
Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials GroupL M Frenkel, E V Capparelli, W M Dankner, et al.
Pageof 4